Harmonization of Alzheimer’s Disease and Related Dementias (AD/ADRD) Genetic, Epidemiologic, and Clinical Data to Enhance Therapeutic Target Discovery (U24 Clinical Trial Not Allowed)

Funding Agency:
National Institutes of Health

The National Institute on Aging (NIA) invites applications specific to infrastructure that will support, under a single cooperative agreement (U24), phenotypic data harmonization on subjects with Alzheimer's Disease Sequencing Project (ADSP) genetic and genomic data. These data will become a long-lived “legacy” data set that will be perpetually curated. The FOA will fund a single vanguard network of researchers with expertise in genetics, epidemiology, and clinical specialties who will work with the ADSP and with study cohort leads on data harmonization efforts to optimize the ability to identify well-targeted therapeutic approaches for Alzheimer's disease and related dementias (AD/ADRD).


  • Letter of Intent: 30 days before due date
  • Due Dates: Jan. 25, May 25, Sep. 25

PAR-20-099 Expiration Date January 26, 2023

Agency Website

Amount Description

Application budgets are limited to $2,771,000 in direct costs per year.

The maximum project period is five years.

    Funding Type





    Medical - Basic Science
    Medical - Clinical Science

    External Deadline

    May 25, 2020